Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-29

Clinical Trial Results: Study to Evaluate SPI-1005 in Adults With Meniere's Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical results for SPI-1005 in adults with Meniere's disease from a Phase 1/2 study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPI-1005

Snippet

Sponsor: Sound Pharmaceuticals, Incorporated | Conditions: Meniere's Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-06-29